Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
JOHNSON & JOHNSON	JNJ	Buenos Aires S.E. +1 Other	10,565	11,386 ARS	Stock
JOHNSON & JOHNSON	JNJD	Buenos Aires S.E.	569	10.9 USD
JOHNSON & JOHNSON	JNJB34	Sao Paulo	6,606	52.45 BRL	Stock
JOHNSON & JOHNSON	JNJ0	Deutsche Boerse AG +1 Other	-	13.5 EUR	Stock
JOHNSON & JOHNSON	JNJ	NEO Exchange	9,822	20.71 CAD
JOHNSON & JOHNSON	JNJ	Nyse +17 Other	7,354,561	154.6 USD	Stock
JOHNSON & JOHNSON	000943981	Berne S.E.	-	140 CHF
JOHNSON & JOHNSON	JNJ	Deutsche Boerse AG	929	141.9 EUR
JOHNSON & JOHNSON	JNJ *	Mexican S.E.	1,197	2,560 MXN
JOHNSON & JOHNSON	JNJ	Swiss Exchange	-	136 USD
JOHNSON & JOHNSON	JNJ	Frankfurt	3,193	141.5 EUR
JOHNSON & JOHNSON	JNJ	Wiener Boerse	32	141.6 EUR
JOHNSON & JOHNSON	0R34	London S.E.	1,193	149.3 USD
JOHNSON & JOHNSON	JNJ	Börse Stuttgart	506	142.2 EUR
JOHNSON & JOHNSON	JNJ	Bolsa De Valores De Colombia	23	5,89,000 COP
JOHNSON & JOHNSON	JNJ	Lima	-	144.5 USD
JOHNSON & JOHNSON	JNJ	Santiago S.E.	-	148.3 USD
JOHNSON & JOHNSON	JNJ	BOERSE MUENCHEN	2,565	142.2 EUR
JOHNSON & JOHNSON	4JNJ	Borsa Italiana	-	139.6 EUR
JOHNSON & JOHNSON	JNJ	Bulgaria S.E.	6	138.7 EUR
JOHNSON & JOHNSON	JNJCL	Santiago S.E.	-	1,55,930 CLP
JOHNSON & JOHNSON	JNJ_KZ	Kazakhstan S.E.	12	153.6 USD
JOHNSON & JOHNSON	JNJ	Swiss Exchange	-	500 CHF
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY	WTW	Nasdaq +5 Other	426,663	257.4 USD	Stock
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY	WTY	Deutsche Boerse AG	-	234 EUR
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY	WTY	Börse Stuttgart	-	236 EUR
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY	0Y4Q	London S.E.	3	250.8 USD
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY	WTY	BOERSE MUENCHEN	-	236 EUR
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY	WTW N	Mexican S.E.	0	4,025 MXN
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY	W1LT34	Sao Paulo	0	335 BRL	Stock
JOHNSON CONTROLS INTERNATIONAL PLC	JCI	Nyse +7 Other	6,209,235	69.02 USD	Stock
JOHNSON CONTROLS INTERNATIONAL PLC	TYIA	Deutsche Boerse AG	112	62.55 EUR
JOHNSON CONTROLS INTERNATIONAL PLC	JCI1 N	Mexican S.E.	0	1,120 MXN
JOHNSON CONTROLS INTERNATIONAL PLC	0Y7S	London S.E.	16	67.13 USD
JOHNSON CONTROLS INTERNATIONAL PLC	TYIA	Börse Stuttgart	-	63.43 EUR
JOHNSON CONTROLS INTERNATIONAL PLC	TYIA	BOERSE MUENCHEN	110	63.32 EUR
JOHNSON CONTROLS INTERNATIONAL PLC	TYIA	Frankfurt	22	53.62 EUR
JOHNSON CONTROLS INTERNATIONAL PLC	TYIA	Berne S.E.	-	- CHF
WILLIS LEASE FINANCE CORPORATION	WLFC	Nasdaq +1 Other	17,704	65.86 USD	Stock
WILLIS LEASE FINANCE CORPORATION	WIJ	Deutsche Boerse AG	-	59 EUR
JOHNSON PHARMACARE LIMITED	SUNSHINE6	Bombay S.E.	1,914,813	1.15 INR	Stock
JOHNSON MATTHEY PLC	JMAT	London S.E. +6 Other	298,212	1,845 GBX	Stock
JOHNSON MATTHEY PLC	JMT2	Deutsche Boerse AG	-	21.1 EUR
JOHNSON MATTHEY PLC	JMAT N	Mexican S.E.	-	811 MXN
JOHNSON MATTHEY PLC	JMT2	Börse Stuttgart	-	21.24 EUR
JOHNSON MATTHEY PLC	JMT2	BOERSE MUENCHEN	-	21.72 EUR
JOHNSON MATTHEY PLC	JMPLF	OTC Markets	904	23.3 USD
JOHNSON MATTHEY PLC	JMAT	Berne S.E.	-	- CHF

See all

News (937)

Transcript : Federal Agricultural Mortgage Corporation - Shareholder/Analyst Call	16/05
Cencora : To Host Inaugural ThinkLive Cell and Gene Therapy Summit	08/05	PU
Continued high inflow of customers and solid earnings	25/04	AQ
Letshego Africa : Notice of Unclaimed Dividends	22/04	PU
Transcript : Hunting PLC - Shareholder/Analyst Call	17/04
Simone Margulies appointed new President and CEO of Axfood	17/04	AQ
Invitation to the presentation of Axfood's first quarter 2024	11/04	AQ
Transcript : Future Generation Australia Limited - Special Call	04/04
Zions Bancorporation N A : 2023 Annual Report Officers & Directors	29/03	PU
Transcript : Flutter Entertainment plc, 2023 Earnings Call, Mar 26, 2024	26/03
Resolutions at Axfood's 2024 Annual General Meeting	21/03	AQ
Axfood's Board of Directors withdraws proposal on an amendment to the Articles of Association	12/03	AQ
Copart, Inc. Announces Board Changes	12/03	CI
Transcript : Costain Group PLC, 2023 Earnings Call, Mar 12, 2024	12/03
Medartis : Corporate Governance Bericht 2023 (ENG)	12/03	PU
Copart Appoints Jeff Liaw as CEO and Director and Jay Adair as Executive Chairman	12/03	PR
'One Love' receives more love at the box office, claiming No. 1 spot for second straight week	26/02	AQ
Axfood publishes Annual and Sustainability Report 2023	23/02	AQ
Notice of Axfood's 2024 Annual General Meeting	13/02	AQ
Klas Balkow will leave his role as President and CEO of Axfood	06/02	AQ
Continued market share gains in an exceptional time	01/02	AQ
Axfood gearing up and phasing out fossil fuels over two-year period	01/02	AQ
Acadia Announces the Passing of Former President Srdjan Stankovic	19/01	AQ
Acadia Announces the Passing of Former President Srdjan (Serge) Stankovic	19/01	BU
Invitation to the presentation of Axfood's year-end report 2023	18/01	AQ
The Nominating Committee's recommendations for changes in the Board of Directors of Axfood	15/01	AQ
The Trump voters in swing states who are returning to the fold	13/01	RE
North American Morning Briefing : Samsung Warning Knocks Tech Stocks	09/01	DJ
Axfood Capital Markets Day 2023: Strong position in a changing market	24/11	AQ
Transcript : The a2 Milk Company Limited - Shareholder/Analyst Call	16/11
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results	07/11	AQ
Transcript : Starbucks Corporation - Special Call	03/11
Acquisition of Industrial Vision Systems Ltd and Issue of Equity	01/11	GL
Acquisition of Industrial Vision Systems Ltd and Issue of Equity	01/11	AQ
Transcript : Southern Cross Media Group Limited - Shareholder/Analyst Call	27/23/27
Continued strong customer traffic and increased market share	25/23/25	AQ
Nominating Committee proposes new Chairman in Axfood	23/23/23	AQ
First U.S. Patients Undergo Innovative Brain Cancer Treatment in New Clinical Trial at HCA Healthcare's Johnston-Willis Hospital	13/23/13	AQ
First U.S. Patients Undergo Innovative Brain Cancer Treatment in New Clinical Trial at HCA Healthcare’s Johnston-Willis Hospital	12/23/12	BU
Invitation to the presentation of Axfood's third quarter 2023	11/23/11	AQ
A New Titan Has Arrived: Inside White Cube Gallery’s Extravagant Opening on Madison Avenue	07/23/07	PU
Hans Bax appointed new Managing Director of Dagab	06/23/06	AQ
Pennsylvania mummy 'Stoneman Willie' to receive proper burial after 128 years	02/23/02	RE
Nominating Committee ahead of Axfood's 2024 Annual General Meeting	22/23/22	AQ
Transcript : Hunting PLC - Analyst/Investor Day	13/23/13

1234NextSee all

Companies (58)

JOHNSON & JOHNSON 372 B $

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...

JOHNSON & JOHNSON 372 B $

ROYALTY PHARMA PLC 12 298 M $

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-ca ...

AXFOOD AB 5 782 M $

Axfood AB is a Sweden-based company engaged in the food retail and wholesale trade in Sweden. The Companyâs retail business is conducted through three wholly owned chains: Willys, specializing in discount food retail; Hemkop, which is engaged in the sal ...

ALLEGION PLC 10 880 M $

Allegion plc specializes in manufacturing and marketing security systems. Products are sold under the Cisa, Interflex, LCN, Schlage, Von Duprin, Aptiq, Bocom, Briton, Bricard, Dexter, Falcon, Glynn-Johnson, Ito Kilit, Ives, Kryptonite, Legge, Normbau, Ste ...

WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY 26 316 M $

Willis Towers Watson Public Limited Company is a world leader in consulting, insurance brokerage and risk management software development. Revenues break down by activity as follows: - human capital and social benefits consulting services (35.6%): consul ...

WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY 26 316 M $

KENVUE INC. 39 196 M $

Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: ...

1234Next

Insiders

Willis Anthony Johnson

Mr. Willis A.
Johnson is a Chief Executive Officer at Willis Johnson & Associates, Inc. He provides a full complement of financial services to individuals as they go through the transitions in their corporate life.
Most corporate professionals will retire once in their life, but Mr. Johnson has assisted hundreds of clients to navigate through the retirement process over the course of his career.
During his over 35 years as an advisor, 13 years with a national financial advisory firm and 22 years as a principal at his own firm, Mr. Johnson implemented exclusive estate and financial planning techniques.
His structured methodology-- customized for each client-- is still the basis of his approach today.
He received a Bachelor of Business Administration in accounting from the University of Houston.

Willis Johnson

Willis J. Johnson is an entrepreneur who founded Copart, Inc., U-PULL-IT, Inc. and Takl, Inc. Presently, Mr. Johnson is Executive Chairman at Copart, Inc. Mr. Johnson is also on the board of Chorespros, Inc. and Takl, Inc. In his past career Mr. Johnson occupied the position of Director at U-PULL-IT, Inc.

Bryan Willis currently works as a Director at Escrowtab, Inc.

No results for this search